Diagnostics (Apr 2021)

Molecular Characterization of Medulloblastoma in a Patient with Neurofibromatosis Type 1: Case Report and Literature Review

  • Marco Ranalli,
  • Alessandra Boni,
  • Anna Maria Caroleo,
  • Giada Del Baldo,
  • Martina Rinelli,
  • Emanuele Agolini,
  • Sabrina Rossi,
  • Evelina Miele,
  • Giovanna Stefania Colafati,
  • Luigi Boccuto,
  • Iside Alessi,
  • Maria Antonietta De Ioris,
  • Antonella Cacchione,
  • Rossella Capolino,
  • Andrea Carai,
  • Sabina Vennarini,
  • Angela Mastronuzzi

DOI
https://doi.org/10.3390/diagnostics11040647
Journal volume & issue
Vol. 11, no. 4
p. 647

Abstract

Read online

Brain tumors are the most common solid neoplasms of childhood. They are frequently reported in children with Neurofibromatosis type 1 (NF1). The most frequent central nervous system malignancies described in NF1 are optic pathway gliomas and brainstem gliomas. Medulloblastoma (MB) in NF1 patients is extremely rare, and to our knowledge, only 10 cases without molecular characterization are described in the literature to date. We report the case of a 14-year-old girl with NF1 that came to our attention for an incidental finding of a lesion arising from cerebellar vermis. The mass was completely resected, revealing a localized classic medulloblastoma (MB), subgroup 4. She was treated as a standard-risk MB with a dose-adapted personalized protocol. The treatment proved to be effective, with minor toxicity. Brain and spine MRI one year after diagnosis confirmed the complete remission of the disease. To our knowledge, this is the only case of MB reported in a patient with NF1 with molecular characterization by the methylation profile. The association between NF1 and MB, although uncommon, may not be an accidental occurrence.

Keywords